Lower Blood Oxygen Saturation is Associated With Microvascular Complications in Individuals With Type 1 Diabetes

被引:3
|
作者
Laursen, Jens Christian [1 ]
Mizrak, Hatice Isik [1 ]
Kufaishi, Huda [1 ]
Hecquet, Sofie Korsgaard [1 ]
Stougaard, Elisabeth Buur [1 ]
Tougaard, Ninna Hahn [1 ]
Frimodt-Moller, Marie [1 ]
Hansen, Tine Willum [1 ]
Hansen, Christian Stevns [1 ]
Rossing, Peter [1 ,2 ]
机构
[1] Steno Diabet Ctr Copenhagen, Complicat Res, Herlev, Capital Region, Denmark
[2] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
关键词
hypoxia; nephropathy; retinopathy; neuropathy; albuminuria; microvascular; macrovascular complications; RETINAL OXYGEN; RENAL DYSFUNCTION; TENSION; HYPOXIA; ADULTS;
D O I
10.1210/clinem/dgac559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Blood oxygen saturation (SpO(2)) is lower in type 1 diabetes (T1D) compared with nondiabetic controls. Hypoxia (low tissue oxygenation) is thought to be a risk factor for progression of diabetic complications, but it is unknown whether hypoxemia (low SpO(2)) is associated with diabetic complications. Objective To test if hypoxemia is associated with presence of diabetic complications in T1D. Design, Setting, and Methods Cross-sectional study in persons with T1D divided by a previously suggested threshold in low (<96%) and high (>= 96%) SpO(2), measured in the supine position with pulse oximetry. Complications included albuminuria (2 of 3 consecutive measurements >= 30 mg/g), any diabetic retinopathy, neuropathy, and history of cardiovascular disease (CVD). Odds ratios were adjusted for age, diabetes duration, sex, smoking, physical activity, body mass index, systolic blood pressure, and blood hemoglobin. Results We included 659 persons, 23 (3.5%) with low and 636 (96.5%) with high SpO(2). In total, 151 (23%) had albuminuria, 233 (36%) had retinopathy, 231 (35%) had neuropathy, and 72 (11%) had CVD. The adjusted odds ratio (95% CI, P value) for low vs high SpO(2) was 3.4 (1.3-8.7, P = 0.01) for albuminuria, 2.8 (1.0-7.5, P = 0.04) for retinopathy, 5.8 (1.8-18.6, P < 0.01) for neuropathy, and nonsignificant for CVD (0.6 [0.2-2.4, P = 0.51]). Conclusions SpO(2) below 96% was associated with increased presence of albuminuria, retinopathy, and neuropathy in T1D, but not with CVD. Whether hypoxemia could be a target of intervention to prevent progression in microvascular disease in type 1 diabetes should be investigated.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 50 条
  • [41] Increased Accumulation of Skin Advanced Glycation End Products Is Associated with Microvascular Complications in Type 1 Diabetes
    Araszkiewicz, Aleksandra
    Naskret, Dariusz
    Niedzwiecki, Pawel
    Samborski, Pawel
    Wierusz-Wysocka, Bogna
    Zozulinska-Ziolkiewicz, Dorota
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (08) : 837 - 842
  • [42] Microvascular Complications Are Associated With Coronary Collateralization in Type 2 Diabetes and Chronic Occlusion
    Gurgoglione, Filippo Luca
    Pitocco, Dario
    Montone, Rocco A.
    Rinaldi, Riccardo
    Bonadonna, Riccardo C.
    Magnani, Giulia
    Calvieri, Camilla
    Solinas, Emilia
    Rizzi, Alessandro
    Tartaglione, Linda
    Flex, Andrea
    Viti, Luca
    Trani, Carlo
    Ardissino, Diego
    Crea, Filippo
    Niccoli, Giampaolo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (01): : E172 - E179
  • [43] Age at menopause was not associated with microvascular complications in patients with type 2 diabetes mellitus
    Sun, Shuyao
    Du, Rong
    Wang, Suyuan
    Guo, Yanhong
    He, Hua
    Wang, Xi
    Zhang, Dan
    Yin, Weijing
    Li, Mingxia
    Wu, Yunhong
    Zhang, Chenghui
    MEDICINE, 2023, 102 (26) : E34066
  • [44] Knowledge, Perceptions and Concerns of Diabetes-Associated Complications among Individuals Living with Type 1 and Type 2 Diabetes Mellitus
    Sanz-Nogues, Clara
    Mustafa, Mohamad
    Burke, Helen
    O'Brien, Timothy
    Coleman, Cynthia M.
    HEALTHCARE, 2020, 8 (01)
  • [45] Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus
    Fröhlich-Reiterer E.E.
    Borkenstein M.H.
    Wiener Medizinische Wochenschrift, 2010, 160 (15-16) : 414 - 418
  • [46] The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
    Kilpatrick, Eric S.
    Rigby, Alan S.
    Atkin, Stephen L.
    DIABETES CARE, 2006, 29 (07) : 1486 - 1490
  • [47] Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes
    Gubitosi-Klug, Rose
    Gao, Xiaoyu
    Pop-Busui, Rodica
    de Boer, Ian H.
    White, Neill
    Aiello, Lloyd P.
    Miller, Ryan
    Palmer, Jerry
    Tamborlane, William
    Wallia, Amisha
    Kosiborod, Mikhail
    Lachin, John M.
    Bebu, Ionut
    DIABETES CARE, 2021, 44 (07) : 1499 - 1505
  • [48] Gastrointestinal Symptoms in Type 1 Diabetes: Relationship With Autoimmune and Microvascular Complications
    De Melo, Emilia N.
    Clarke, Antoine B. M.
    McDonald, Charlotte
    Saibil, Fred
    Lochnan, Heather A.
    Punthakee, Zubin
    Assor, Esther
    Marcon, Margaret A.
    Mahmud, Farid H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (06): : E2431 - E2437
  • [49] Angiotensin converting enzyme polymorphism and microvascular complications in type 1 diabetes
    Bertacca, A
    Pucci, L
    Penno, G
    Nannipieri, M
    Rizzo, L
    Rapuano, A
    DIABETOLOGIA, 1996, 39 : 1135 - 1135
  • [50] Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus
    João Soares Felício
    Lilian de Souza d’Albuquerque Silva
    Carlliane Lima e Lins Pinto Martins
    João Felício Abrahão Neto
    Manuela Nascimento de Lemos
    Fabrício de Souza Resende
    Wanderson Maia da Silva
    Angélica Leite de Alcântara
    Maria Clara Neres Iunes de Oliveira
    Norberto Jorge Kzan de Souza Neto
    Isabela Imbelloni Farias de Franco
    Nathalie Abdallah Zahalan
    Luísa Correa Janaú
    Ana Carolina Contente Braga de Souza
    Flavia Marques Santos
    Natércia Neves Marques de Queiroz
    Neyla Arroyo Lara Mourão
    Márcia Costa dos Santos
    Karem Miléo Felício
    Franciane Trindade Cunha de Melo
    Diabetology & Metabolic Syndrome, 10